S 2512 · 114th Congress 2015–2017, ended

Adding Zika Virus to the FDA Priority Review Voucher Program Act

Fact sheet

Latest action · Apr 19, 2016 Became Public Law No: 114-146.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedFeb 8, 2016
  2. Passed SenateMar 17, 2016
  3. Passed HouseApr 12, 2016
  4. To the PresidentApr 14, 2016
  5. Became lawApr 19, 2016

Summary

(This measure has not been amended since it was reported to the Senate on March 15, 2016. The summary of that version is repeated here.)

Adding Zika Virus to the FDA Priority Review Voucher Program Act

(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to add Zika virus disease to the list of tropical diseases under the priority review voucher program, which awards a voucher to the sponsor of a new drug or biological product that is approved to prevent or treat a tropical disease. (A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.)

The bill makes a technical correction to the tropical disease list to refer to filovirus disease, a condition caused by the family of viruses that includes the Ebola virus, instead of the family of viruses.

Cosponsors 11

Members who signed on, in the order they did. Signatures ran from Feb 8, 2016 to Mar 15, 2016, with 3 there on the day it was introduced.

SeatCosponsorSigned on
D-FLBill NelsonOriginalFeb 8, 2016
R-GAJohnny IsaksonOriginalFeb 8, 2016
D-OHSherrod BrownOriginalFeb 8, 2016
R-ILMark KirkFeb 10, 2016
D-NJRobert MenendezFeb 10, 2016
R-OHRob PortmanFeb 24, 2016
D-PARobert P. Casey Jr.Feb 24, 2016
D-MNAmy KlobucharMar 10, 2016
D-CTChristopher MurphyMar 10, 2016
D-WAPatty MurrayMar 10, 2016
R-TNLamar AlexanderMar 15, 2016

Actions 20

Everything that happened, newest first.

  1. Apr 19, 2016Became Public Law No: 114-146.
  2. Apr 19, 2016Signed by President.
  3. Apr 14, 2016Presented to President.
  4. Apr 12, 2016Considered under suspension of the rules. (consideration: CR H1602-1605)
  5. Apr 12, 2016DEBATE - The House proceeded with forty minutes of debate on S. 2512.

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
HR 4400Adding Zika Virus to the FDA Priority Review Voucher Program ActIdentical billFeb 5, 2016

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 5

Each version as it was printed, newest first.

  1. —Enrolled Bill
  2. Mar 21, 2016Referred in House
  3. Mar 17, 2016Engrossed in Senate
  4. Mar 15, 2016Reported to Senate
  5. Feb 8, 2016Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.